← Back to Search

Hypnosis for Hot Flashes in Breast Cancer Survivors

N/A

Waitlist Available

Led By Gary Elkins, PhD

Research Sponsored by Scott and White Hospital & Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Experiencing at least 14 hot flashes per week for ≥ 1 month by self-reporting

Outpatient status

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is testing whether hypnosis can help reduce hot flashes in breast cancer survivors.

Who is the study for?

This trial is for female breast cancer survivors who are experiencing frequent hot flashes (at least 14 per week) and have been doing so for over a month. They should be on stable antihormonal therapy if any, not undergoing chemotherapy, and without psychiatric conditions that affect study participation.Check my eligibility

What is being tested?

The trial is examining the effectiveness of hypnosis in reducing hot flashes among breast cancer survivors. Participants will be randomly assigned to receive hypnosis with the goal of seeing if it helps manage their symptoms.See study design

What are the potential side effects?

Hypnosis is generally considered safe but may cause temporary dizziness, anxiety, or disorientation immediately after the session. Long-term side effects are rare when performed by a trained professional.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had more than 14 hot flashes a week for at least a month.

Select...

I am not currently admitted to a hospital.

Select...

I had breast cancer but now show no signs of the disease.

Select...

I am female.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Hot flash control by Hot Flash Daily Diary in week 6

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Scott and White Hospital & ClinicLead Sponsor

22 Previous Clinical Trials

32,424 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,667 Previous Clinical Trials

40,926,106 Total Patients Enrolled

33 Trials studying Hot Flashes

3,549 Patients Enrolled for Hot Flashes

Gary Elkins, PhDPrincipal InvestigatorScott and White Hospital & Clinic

Media Library

Hypnosis Clinical Trial Eligibility Overview. Trial Name: NCT00094133 — N/A

Hot Flashes Clinical Trial 2023: Hypnosis Highlights & Side Effects. Trial Name: NCT00094133 — N/A

Hypnosis 2023 Treatment Timeline for Medical Study. Trial Name: NCT00094133 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining spots available for participants in this investigation?

"According to clinicaltrials.gov, this research project is not presently recruiting participants; the protocol was initially published on April 1st 2006 and most recently edited on September 19th 2013. Nonetheless, there are over two thousand six hundred forty-three other investigations accepting patients at present."

Answered by AI